Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-82.51	-322.67	1845.27
Graham Fair Price	59.55	2.69	1.69
PEG	-83.98	-0.57	3.56
Price/Book	10.72	-55.20	-61.82
Price/Cash Flow	-19.40	186.50	231.41
Prices/Earnings	70.18	-98.18	-329.27
Price/Sales	-21.21	26.13	33.16
Price/FCF	-19.40	186.50	231.41
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.20	0.76	0.77
Operating Margin	-83.10	-0.10	-0.06
ROA	-182.46	< 0.005	< 0.005
ROE	0.05	0.14	199.41
ROIC	-0.02	-0.03	-36.05
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-57.51
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.39	-0.93	138.57
EPS QOQ	0.93	-1.72	86.18
FCF QOQ	0.70	0.03	-95.65
Revenue QOQ	0.05	0.05	0.91
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	92.80	0.00	inf
Days Sales Outstanding (DSO)	71.59	48.70	-31.97
Inventory Turnover	0.97	0.00	inf
Debt/Capitalization	1.13	1.12	-0.50
Quick Ratio	1.95	2.00	2.35
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-1.64	-1.51	7.79
Cash	14.95	15.27	2.12
Capex	< 0.005	< 0.005	49.58
Free Cash Flow	0.44	0.45	2.14
Revenue	3.06	3.20	4.48
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.08	2.05	-1.36
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	163.45	-31.46	-80.75
Naive Interpretation	Member

06 - Financial Health · Bad

Rating